BioCentury
ARTICLE | Clinical News

Cenderitide regulatory update

April 4, 2011 7:00 AM UTC

FDA granted Fast Track designation for Nile's cenderitide to treat patients with acute decompensated heart failure (ADHF) in the post-acute period. Nile plans to start a Phase II trial of the selectiv...